| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 60, 1268-1269, Copyright © 1985 by Endocrine Society
ARTICLES |
JP Hart, MJ Shearer, L Klenerman, A Catterall, J Reeve, PN Sambrook, RA Dodds, L Bitensky and J Chayen
If gamma-carboxylation, by the vitamin K1 - cycle, of glutamate residues of bone-matrix peptides is essential for the formation of bone, the circulating levels of this vitamin might indicate the potential efficiency of this process. Methods involving HPLC with electrochemical detection have very recently been developed for assaying the low levels of vitamin K1 that occur in normal plasma. Using such methods, we found that the circulating levels of vitamin K1 in osteoporotic patients (who had sustained either spinal crush- fractures or fractures of the neck of the femur) were significantly lower than those of age-matched control subjects.
This article has been cited by other articles:
![]() |
D. A. Pearson Bone Health and Osteoporosis: The Role of Vitamin K and Potential Antagonism by Anticoagulants Nutr Clin Pract, October 1, 2007; 22(5): 517 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cockayne, J. Adamson, S. Lanham-New, M. J. Shearer, S. Gilbody, and D. J. Torgerson Vitamin K and the Prevention of Fractures: Systematic Review and Meta-analysis of Randomized Controlled Trials. Arch Intern Med, June 26, 2006; 166(12): 1256 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W Nieves Osteoporosis: the role of micronutrients Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1232S - 1239S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Tabb, A. Sun, C. Zhou, F. Grun, J. Errandi, K. Romero, H. Pham, S. Inoue, S. Mallick, M. Lin, et al. Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR J. Biol. Chem., November 7, 2003; 278(45): 43919 - 43927. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. J. L. M. Braam, M. H. J. Knapen, P. Geusens, F. Brouns, and C. Vermeer Factors Affecting Bone Loss in Female Endurance Athletes: A Two-Year Follow-Up Study Am. J. Sports Med., November 1, 2003; 31(6): 889 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Fairfield and R. H. Fletcher Vitamins for Chronic Disease Prevention in Adults: Scientific Review JAMA, June 19, 2002; 287(23): 3116 - 3126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Eastell, D.M. Reid, J. Compston, C. Cooper, I. Fogelman, R.M. Francis, S.M. Hay, D.J. Hosking, D.W. Purdie, S.H. Ralston, et al. Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? QJM, November 1, 2001; 94(11): 575 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Feskanich, P. Weber, W. C Willett, H. Rockett, S. L Booth, and G. A Colditz Vitamin K intake and hip fractures in women: a prospective study Am. J. Clinical Nutrition, January 1, 1999; 69(1): 74 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, Y. Honda, H. Kunoh, and K. Oizumi Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation Stroke, December 1, 1997; 28(12): 2390 - 2394. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |